BeOne Medicines (BEIGF) Debt to Equity (2015 - 2026)
BeOne Medicines (BEIGF) reported Debt to Equity of $0.23 for Q1 2026, down 14.15% year-over-year from $0.26 in Q1 2025, and down 3.04% quarter-over-quarter from $0.23 in Q4 2025.
BeOne Medicines (BEIGF) Debt to Equity (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of Debt to Equity data on file, last reported at $0.23 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.23, down 14.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.23 (down 14.15% YoY), and the FY2025 annual result was $0.23, down 23.5% from the prior year.
- Debt to Equity retreated to $0.23 in Q1 2026 per BEIGF's latest filing, from $0.23 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.4 in Q3 2025 and troughed at $0.05 in Q4 2022.
- A 5-year average of $0.22 and a median of $0.23 in 2025 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2022 and 2023: Debt to Equity tumbled 53.53% in 2022, then soared 424.93% in 2023.
- A 5-year view of Debt to Equity shows it stood at $0.05 in 2022, then soared by 424.93% to $0.25 in 2023, then gained by 21.97% to $0.31 in 2024, then retreated by 23.5% to $0.23 in 2025, then fell by 3.04% to $0.23 in 2026.
- Business Quant data shows BEIGF's Debt to Equity at $0.23 in Q1 2026, $0.23 in Q4 2025, and $0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | 0.31 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.25 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.17 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.14 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.11 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | 0.19 |
| Jun 30, 2021 | 0.17 |